Bulk Orders 20+ vials
Volume pricing applies automatically from three vials and reaches 20% at twenty. Larger runs, institutional supply and custom timelines get a quote.
Ask about bulk
Bioregulator
Vesugen is a peptide research product supplied as a 20MG lyophilized research vial.
Bundle & save
Referral program · researchers save 10%, you earn 15% backThe compounds researchers order most, by verified order volume.
More ways to save
Volume pricing applies automatically from three vials and reaches 20% at twenty. Larger runs, institutional supply and custom timelines get a quote.
Ask about bulkVerified test results
Each batch is analyzed by ILS Laboratories, an independent ISO/IEC 17025 accredited lab, before release. Below is the report for lot VG01, summarized from the certificate the lab published.
This lot ships under its own published certificate. Open any certificate below, exactly as the lab released it.
Side by side
Technical specifications
Important research notice
Not for human, veterinary, or food use. This product is sold exclusively for laboratory research purposes. It is not intended to diagnose, treat, cure, or prevent any disease, and has not been evaluated by the FDA.
All referenced publications and registries are sourced from peer-reviewed journals and official registries. They are provided for educational reference only and are not product claims.
By purchasing, you confirm you are a qualified researcher and will handle this product in accordance with all applicable laws and regulations.
Ready when you are
The lot on this page links to the signed certificate for that batch.
Vesugen is a premium peptide research product supplied as a 20MG lyophilized research vial. Vesugen is studied in controlled laboratory models involving vascular peptide pathway research, endothelial cell signaling, microcirculation-associated models, angiogenesis-pathway investigations, extracellular matrix response systems, and cardiovascular tissue-response research.
Disguised Alpha Vesugen is supplied in a clean lyophilized research format for laboratories requiring clear 20MG strength labeling, peptide identity transparency, careful handling standards, internal QA review, documentation support, and direct in-house fulfillment.
Compound: Vesugen
Strength: 20MG
Total Content: 20MG Vesugen
Format: Lyophilized peptide research vial
Research Category: Vascular / endothelial / cardiovascular pathway research
Research Focus: Vascular peptide pathway research, endothelial cell signaling, microcirculation-associated models, angiogenesis-pathway investigations, extracellular matrix response systems, and cardiovascular tissue-response studies.
Vesugen is studied in laboratory models involving vascular-associated peptide signaling, endothelial response pathways, microcirculation-linked research, angiogenesis-associated systems, and extracellular matrix pathway behavior.
Studied in models involving vascular tissue-response systems, endothelial pathway behavior, and cardiovascular-associated peptide signaling.
Relevant to controlled investigations involving endothelial cell signaling, microcirculation-associated models, angiogenesis-linked pathways, and cellular-response systems.
Supplied as a clearly labeled 20MG lyophilized peptide research vial for structured documentation, handling, and laboratory workflow organization.
Vesugen is studied in laboratory models involving vascular peptide signaling, endothelial response pathways, microcirculation-associated systems, angiogenesis-linked activity, extracellular matrix behavior, and cardiovascular tissue-response research.
Research interest in Vesugen centers on how vascular-associated peptide structures may be evaluated in models involving endothelial cellular behavior, connective tissue response, microvascular pathway signaling, and cardiovascular research systems under controlled laboratory conditions.
Peptide research products require more oversight than a simple compound listing. Identity clarity, strength presentation, vial appearance, documentation, storage expectations, label accuracy, packaging quality, and fulfillment handling all matter.
Disguised Alpha reviews Vesugen as a complete peptide research product with attention to 20MG strength presentation, lyophilized vial appearance, product documentation, internal QA, labeling accuracy, and direct fulfillment accountability.
We believe researchers should be able to verify the standards we speak about. Learn more about the independent laboratories we work with below.
Visit ILS Labs Visit ChromateDisguised Alpha is built around direct accountability. Every order is processed, inspected, packaged, and shipped by our in-house team instead of being passed off to a third-party logistics warehouse.
This gives us tighter control over formulation quality, fulfillment accuracy, packaging standards, storage conditions, and customer experience. Our goal is not to be the cheapest research supplier. It is to provide professionally handled compounds with real quality oversight behind them.
Research Use Disclaimer: This product is sold strictly for laboratory research purposes only. It is not intended for human consumption, animal use, medical use, diagnostic use, therapeutic use, cardiovascular treatment use, blood-pressure use, circulation support use, vascular treatment use, angiogenesis therapy use, wound-healing use, recovery use, anti-aging use, performance-enhancement use, injection use, topical use, self-administration use, supplement use, or the treatment, prevention, or diagnosis of any disease. Researchers are responsible for ensuring proper handling, storage, compatibility review, preparation review, safety review, and compliance with all applicable regulations.The synthetic tripeptide Lys-Glu-Asp (KED), coded T-38 in some papers and spelled vezugen in some Russian-language papers, from the short-peptide program of the St Petersburg Institute of Bioregulation and Gerontology. PubChem files it as Lys-Glu-Asp (C₁₅H₂₆N₄O₈, 390.39 g/mol for the free peptide) and has no record under the name vesugen.
No. Cartalax is Ala-Glu-Asp (AED) and vesugen is Lys-Glu-Asp (KED): they share Glu-Asp and differ at the first residue, alanine versus lysine. Both come from the same St Petersburg program, whose 2021 review lists them as separate peptides, and a 2020 study tested them side by side in human embryonic bone marrow mesenchymal stem cell cultures.
Mostly explants and cell cultures: rat spleen, skin and pineal explants, vascular and endothelial cell cultures, human thymocytes, fibroblasts and mesenchymal stem cells, mouse hippocampal neurons and neurons induced from donor fibroblasts, plus 5xFAD mice. Each of these studies lists V. Kh. Khavinson or colleagues from the St Petersburg Institute of Bioregulation and Gerontology among its authors.
This page sells Vesugen as a peptide research product supplied as a 20MG lyophilized research vial, lyophilized in the USA. Each batch is analyzed by ILS Laboratories before release, and the current lot's certificate of analysis is shown on this page. It is sold exclusively for laboratory research purposes and ships from Irvine, California, by FedEx 2-Day shipping.
Match the selected product option and assigned shipping lot to the corresponding report in the COA portal. Check the compound or components, sample identification, test date, methods and results actually reported. Results for another lot or formulation are not a substitute.
No. Analytical purity and measured content are different measurements. Compare labeled quantity with measured content only where the report provides a compatible result and unit.
Read the Vesugen research reference. For batch documentation or formulation questions, contact Disguised Alpha.
Vesugen is a peptide research product supplied as a 20MG lyophilized research vial.
The current certificate is matched to the selected product option and assigned shipping batch.
Enable JavaScript to view the certificate for your selected option.